Mapping Current and Emerging Laboratory Techniques for Haemoglobinopathy Carrier Detection and Prevention: A Narrative Review from the HELIOS Action
International Journal of Molecular Sciences, vol. 27, pp. 3916
Abstract
Haemoglobinopathies remain a major public health challenge, predominantly in endemic regions. Increasing migration has extended their prevalence in previously non-endemic areas, complicating early detection and prevention. As part of the HELIOS CA22119 COST Action Working Group 1, this narrative review critically examines established and emerging laboratory techniques for haemoglobinopathy carrier detection. It also explores diagnostic limitations, regional disparities, and opportunities for global harmonisation to support early detection, prevention, and equitable care. A literature search of MEDLINE, PubMed, Scopus, and EMBASE (2014-2024) identified studies on the screening, diagnosis, and prevention of haemoglobinopathies. Findings were synthesised across three domains: (1) preventive strategies, (2) carrier screening methods, and (3) prenatal diagnostic approaches. Advances in molecular technologies have improved diagnostic sensitivity and specificity. However, conventional haematological approaches, particularly complete blood count and haemoglobin typing, remain essential and cost-effective first-line tools. Key challenges include unequal access to advanced diagnostics and the lack of standardised protocols across regions. Strengthening prevention requires coordinated global efforts to promote accessible, accurate, and standardised diagnostic approaches tailored to regional genomic, economic, and healthcare contexts. Early and equitable carrier detection, combined with effective prenatal diagnosis, is critical to reducing the global burden and improving health outcomes in both endemic and emerging regions.
Authors 10
-
Leiden University Medical Center · Institute for Medical Research · National Institutes of Health
Affiliation as printed
Department of Clinical Genetics/LDGA, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
Haematology Unit, Cancer Research Centre (CaRC), Institute for Medical Research (IMR), National Institute for Health (NIH), Setia Alam 40170, Selangor, Malaysia
-
Cyprus Institute of Neurology and Genetics
Affiliation as printed
Department of Blood Disorder Genetics and Thalassaemia, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus
-
Affiliation as printed
Faculty of Medicine, University of Medicine, 1005 Tirana, Albania
-
Vall d'Hebron Hospital Universitari · Vall d'Hebron Institute of Oncology
Affiliation as printed
Haematology Molecular Genetics Unit, Department of haematology, Hospital Universitari Vall d’Hebron (HUVH), Experimental Haematology, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain
-
Universidade Politécnica de Lisboa · Centro de Investigação em Saúde e Tecnologia
Affiliation as printed
Health and Technology Research Center, Escola Superior de Saúde de Lisboa, Instituto Politécnico de Lisboa, 1990-096 Lisboa, Portugal
-
Affiliation as printed
Human Genetics and Genome Research Institute, National Research Centre, Cairo 12622, Egypt
-
Affiliation as printed
Center of Molecular Diagnostic and Genetics Research, University Hospital Obstetrics and Gynecology “Mbretëresha Geraldinë”, 1045 Tirana, Albania
Department of Biology, Faculty of Natural Sciences, University of Tirana, 1009 Tirana, Albania
-
Cyprus Institute of Neurology and Genetics
Affiliation as printed
Department of Blood Disorder Genetics and Thalassaemia, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus
-
Cyprus Institute of Neurology and Genetics
Affiliation as printed
Department of Blood Disorder Genetics and Thalassaemia, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus
-
National and Kapodistrian University of Athens
Affiliation as printed
School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-11).